To view this email as a web page, click here.

December 4, 2018
 
Combination therapies may be best for tattoo removal
image description here From Dermatology Times
While nano-second Q-switched lasers (ns-lasers) are still considered the gold standard for tattoo clearance, newer methods such as picosecond lasers (ps-lasers) and combination therapies might hold more promise in effectively removing tattoos.

Read more
 
7 Safety recommendations for tattoo removal
image description here From Dermatology Times
Investigators from the Health Hazard Evaluation Program of the Centers for Disease Control and Prevention recently issued these seven must-know safety recommendations for tattoo removal.

Read more
 
Investing in technology: What you need to know
image description here From Medical Economics
Choosing the right technology for your practice can be overwhelming, so we reached out to physicians, healthcare technology experts and financial consultants across the U.S. to ask what doctors should consider before investing in technology. Here's what they said.

Read more
 
ADVERTISEMENT
How can you stay clinically current in a rapidly expanding field?
The 17th Annual South Beach Symposium, taking place from February 7-10, 2019 in Miami Beach at the Loews Hotel, provides attendees with the most comprehensive education in clinical & aesthetic dermatology. Learn more.
 
We want to hear from you!
 
Have comments or questions about the eNewsletter? Contact us!
The Aesthetic Channel editor Eliza Cabana at eliza.cabana@ubm.com
The Aesthetic Guide editor Erin Velardo at erin.velardo@ubm.com
Channel Director Heather Onorati at heather.onorati@ubm.com
 
ADVERTISEMENT
The Cosmetic Professional’s Guide to Patient Financing
Would you like to grow your revenue while saving thousands in provider fees? Download the Ultimate Guide to Patient Financing to learn how! Learn more.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.